Drugs · acquisition-cost intelligence
Esomeprazole Magnesium for delayed-release oral suspension
Esomeprazole magnesium· ingredient esomeprazoleProton pump inhibitors· ESOMEPRAZOLE MAGNESIUM 20 mg/1; ESOMEPRAZOLE MAGNESIUM 2.5 mg/1; ESOMEPRAZOLE MAGNESIUM 40 mg/1; ESOMEPRAZOLE MAGNESIUM 5 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$5.08
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 8 weeks.
2025-12-172026-06-03
Same-ingredient options by acquisition cost
Other esomeprazole products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Esomeprazole Magnesium DR | $0.13164 | −$4.95 |
| basic care esomeprazole magnesium | $0.16281 | −$4.92 |
| Naproxen and esomeprazole magnesium | $2.57 | −$2.51 |
| Esomeprazole Magnesium for delayed-release oral suspension | $5.97 | +$0.89050 |
| Esomeprazole magnesium | $6.20 | +$1.12 |
Medicare Part D coverage · CY2026
On 79 plan formularies · typical tier 4
Prior auth 0% · Step therapy 62% · Quantity limit 84% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.